Skip to content

Effect of Transcranial Photobiomodulation on Postoperative Sleep Disturbances in Patients Undergoing Gynecological Laparoscopic Surgery

Effect of Transcranial Photobiomodulation on Postoperative Sleep Disturbances in Patients Undergoing Gynecological Laparoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119019
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disturbance

Interventions

Transcranial Light Stimulation Group:Transcranial Light Stimulation, tLS
Control group:sham-tLS

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Before starting trial-related activities, voluntarily sign the informed consent form, fully understand the purpose and significance of this experiment, and voluntarily comply with the trial procedures; 2. Planned elective gynecological laparoscopic surgery under general anesthesia with an expected duration of 1 to 3 hours; 3. Age 18 to 65 years; 4. American Society of Anesthesiologists (ASA) physical status classification I or II; 5. Body mass index (BMI) between 18 kg/m^2 and 30 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Pittsburgh Sleep Quality Index (PSQI) > 7 points; 2. Preoperative neurological or psychiatric disorders (such as depression, Parkinson's disease, schizophrenia, epilepsy, etc.) or sleep-related disorders (such as obstructive sleep apnea syndrome, etc.); 3. History of brain disease (such as cerebral infarction, cerebral hemorrhage, intracranial lesions, traumatic brain injury, etc.); 4. History of neurosurgery; 5. Cognitive or communication impairments; 6. Long-term use of sedative or hypnotic drugs; 7. Severe liver or kidney dysfunction; 8. Pregnancy or breastfeeding; 9. Refusal to participate in this study; 10. Other conditions judged by the researcher that make the subject unsuitable for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Incidence of sleep disorder on the first night after operation;

Secondary

MeasureTime frame
Hospital Anxiety and Depression Scale;waking time;Adverse event;Opioid drug consumption;Incidence of sleep disorder on the 2nd, 3rd and 7th night after operation;electroencephalogram;Pain score;

Countries

China

Contacts

Public ContactYang Jianjun

The First Affiliated Hospital of Zhengzhou University

jianjunyang1971@163.com+86 371 66862025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026